Bio-Techne (TECH) has expanded its COMET spatial biology platform with new SPYRE Focus Panels, SPYRE Amplification Kits, and updated HORIZON image analysis tools, a product move that matters for the ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Bio-Techne Corp. closed 27.94% short of its 52-week high of $72.16, which the company achieved on January 22nd.

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Bio-Techne (TECH) is back in focus after institutional ...

A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average ...

Bio-Techne TECH continues to expand its portfolio and enter adjacent markets via acquisitions and strategic investments. Strength in international markets underscores the company’s growth potential.

Shares of Bio-Techne Corp. TECH rose 1.54% to $51.59 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.27% to 6,606.49 and ...

Investing.com - TD Cowen reiterated a Buy rating and $80.00 price target on Bio-Techne Corp. (NASDAQ:TECH) following a decline in the company’s shares. Bio-Techne shares fell 4% Tuesday after ...

Investing.com - Argus raised its price target on Bio-Techne Corp. (NASDAQ:TECH) shares to $68 from $65 while maintaining a Buy rating on the stock. The company, with a market capitalization of $8.4 ...

As the head of CBS News, Neeraj Khemlani kept looking for stories that would snare the interest of large crowds. Though he ...

Minneapolis, Minnesota-based Bio-Techne Corporation (TECH) develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets ...